
Delivering Value & Access solutions for Market Access, Pricing, HEOR and Medical Affairs organizations
Access Strategies
Optimize patient access and reimbursement through evidence-based and innovative strategic thinking
Value Strategies
Ensuring you have the best in class value demonstration strategies and dissemination plan
Management Consulting
Unlocking your full organizational potential
Delivering Value & Access solutions for Market Access, Pricing, HEOR and Medical Affairs organizations
AESARA is a boutique consulting firm with biopharma DNA, who can help you optimize patient access and reimbursement through evidence-based and innovative strategic thinking.
Description
Description
AESARA's core offerings are below:
VALUE & ACCESS CONSULTING
- Market Access & Value Strategy​​
- Payer Research & Advisory Boards​
- Value Proposition​
- Value Communication Tools​
- Inflation Reduction Act (IRA)/PDAB Readiness​
- Health Technology Assessment (HTA) Submissions​
- Endpoint Strategy​
- Value-based Pricing/Agreements​
- Time & Materials (T&M) Support & Staff Extenders​
- Launch Planning​
- HTA Landscape and Competitive Assessments​
- Coding, Billing and Reimbursement Strategy
HEOR CONSULTING
- Integrated Evidence Generation Planning (IEGP)​
- Comprehensive Patient Perspective​
- Literature Reviews​
- Global Value and AMCP Dossiers​
- Economic Modeling​
- Real-World Evidence (RWE) Strategy & Study Design​
- Evidence Gap Analyses​
- Clinical Outcome Assessment (COA) Strategy​
- Retrospective Chart Reviews​
- ICER Readiness​
- Delphi Panels
MANAGEMENT CONSULTING
- Education & Training​
- Vision Casting​
- Organization Transformation​
- Organization Design​
- Team Competency Development​
- Key Performance Indicators (KPIs) Development​
- Function Branding and Positioning​
- Internal Communications​
- Process Design and Improvement ​(e.g., Operationalizing FDA Payer Guidance, Patient Experience Data Communications Framework)
EUROPE OFFERINGS
- EU JCA PICO prediction & Dossier development
- Lifecycle Management (LCM) Strategy
- EU JCA Process & Governance Design
VALUE & ACCESS CONSULTING
- Market Access & Value Strategy​​
- Payer Research & Advisory Boards​
- Value Proposition​
- Value Communication Tools​
- Inflation Reduction Act (IRA)/PDAB Readiness​
- Health Technology Assessment (HTA) Submissions​
- Endpoint Strategy​
- Value-based Pricing/Agreements​
- Time & Materials (T&M) Support & Staff Extenders​
- Launch Planning​
- HTA Landscape and Competitive Assessments​
- Coding, Billing and Reimbursement Strategy
HEOR CONSULTING
- Integrated Evidence Generation Planning (IEGP)​
- Comprehensive Patient Perspective​
- Literature Reviews​
- Global Value and AMCP Dossiers​
- Economic Modeling​
- Real-World Evidence (RWE) Strategy & Study Design​
- Evidence Gap Analyses​
- Clinical Outcome Assessment (COA) Strategy​
- Retrospective Chart Reviews​
- ICER Readiness​
- Delphi Panels
MANAGEMENT CONSULTING
- Education & Training​
- Vision Casting​
- Organization Transformation​
- Organization Design​
- Team Competency Development​
- Key Performance Indicators (KPIs) Development​
- Function Branding and Positioning​
- Internal Communications​
- Process Design and Improvement ​(e.g., Operationalizing FDA Payer Guidance, Patient Experience Data Communications Framework)
EUROPE OFFERINGS
- EU JCA PICO prediction & Dossier development
- Lifecycle Management (LCM) Strategy
- EU JCA Process & Governance Design

Share
Recent Chats
Share via email
Future: handle WhatsApp here
Future: handle LinkedIn here
Future: handle Twitter here
SUBMENU HERE
Share via Chat
Copy Link